WallStreetZenWallStreetZen

NASDAQ: CNTG
Centogene Nv Stock

$1.31+0.00 (+0%)
Updated Feb 3, 2023
CNTG Price
$1.31
Fair Value Price
$2.54
Market Cap
$35.34M
52 Week Low
$0.68
52 Week High
$4.94
P/E
-0.51x
P/B
1.57x
P/S
0.54x
PEG
N/A
Dividend Yield
N/A
Revenue
$100.66M
Earnings
-$52.57M
Gross Margin
16.4%
Operating Margin
-49.03%
Profit Margin
-52.8%
Debt to Equity
3.27
Operating Cash Flow
-$23M
Beta
0.44
Next Earnings
Mar 28, 2023
Ex-Dividend
N/A
Next Dividend
N/A

CNTG Overview

Centogene N.V., together with its subsidiaries, focuses on rare diseases that transforms real-world clinical and genetic, or other data into actionable information for patients, physicians, and pharmaceutical companies worldwide. It operates through three segments: Pharmaceutical, Diagnostics, and COVID-19 testing. The company develops rare disease platform, a data and biological repository, which includes epidemiologic, phenotypic, and heterogenetic data that enhances methods for identifying and monitoring rare hereditary diseases and provide solutions that accelerate the development of orphan drugs. It provides various services, including target discovery, early patient recruitment and identification, epidemiological insights, biomarker discovery, and patient monitoring; and genetic sequencing and diagnostics services to physicians, laboratories, or hospitals directly or through distributors. The company also offers COVID-19 testing solutions, including PCR and antigen testing services. It has collaboration and license agreements with Shire International GmbH, Pfizer Inc., Dr. Bauer Laboratoriums GmbH, Fraport AG, Takeda Pharmaceutical Company Limited, and Twist Bioscience Corporation. Centogene N.V. was founded in 2006 and is headquartered in Rostock, Germany.

Zen Score

Industry Average (30)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how CNTG scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

CNTG ($1.31) is undervalued by 48.54% relative to our estimate of its Fair Value price of $2.54 based on Discounted Cash Flow (DCF) modelling, but does not have a significant margin of safety
Below Fair Value Valuation
CNTG ($1.31) is significantly undervalued by 48.54% relative to our estimate of its Fair Value price of $2.54 based on Discounted Cash Flow (DCF) modelling, which includes a healthy margin of safety
Significantly Below Fair Value Valuation
CNTG is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more CNTG due diligence checks available for Premium users.

Be the first to know about important CNTG news, forecast changes, insider trades & much more!

CNTG News

Valuation

CNTG fair value

Fair Value of CNTG stock based on Discounted Cash Flow (DCF)
Price
$1.31
Fair Value
$2.54
Undervalued by
48.34%
CNTG ($1.31) is undervalued by... subscribe to Premium to read more.
Below Fair Value Valuation
CNTG ($1.31) is significantly undervalued... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
CNTG is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

CNTG price to earnings (PE)

For valuing profitable companies with steady earnings
Company
-0.51x
Industry
37.84x
Market
15.09x

CNTG price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
1.57x
Industry
4.54x
CNTG is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

CNTG's financial health

Profit margin

Revenue
$11.8M
Net Income
-$10.7M
Profit Margin
-90.6%
CNTG's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
CNTG's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$94.9M
Liabilities
$72.7M
Debt to equity
3.27
CNTG's short-term assets ($58.87M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
CNTG's short-term assets ($58.87M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
CNTG's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$5.5k
Investing
-$702.0
Financing
-$3.4k
CNTG's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

CNTG vs Diagnostic & Research Stocks

TickerMarket Cap1d %P/EP/B
CNTG$35.34M-0.38%-0.51x1.57x
BWAY$35.11M-0.48%-3.27x0.72x
GENE$33.61M+80.20%-5.38x2.90x
PMD$31.10M-1.96%-15.31x2.65x
BMRA$39.90M+0.34%-6.88x5.51x

Centogene Nv Stock FAQ

What is Centogene Nv's quote symbol?

NASDAQ: CNTG) Centogene Nv trades on the NASDAQ under the ticker symbol CNTG. Centogene Nv stock quotes can also be displayed as NASDAQ: CNTG.

If you're new to stock investing, here's how to buy Centogene Nv stock.

What is the 52 week high and low for Centogene Nv (NASDAQ: CNTG)?

(NASDAQ: CNTG) Centogene Nv's 52-week high was $4.94, and its 52-week low was $0.68. It is currently -73.58% from its 52-week high and 91.91% from its 52-week low.

How much is Centogene Nv stock worth today?

(NASDAQ: CNTG) Centogene Nv currently has 27,081,557 outstanding shares. With Centogene Nv stock trading at $1.31 per share, the total value of Centogene Nv stock (market capitalization) is $35.34M.

Centogene Nv stock was originally listed at a price of $12.49 in Nov 7, 2019. If you had invested in Centogene Nv stock at $12.49, your return over the last 3 years would have been -89.55%, for an annualized return of -52.9% (not including any dividends or dividend reinvestments).

How much is Centogene Nv's stock price per share?

(NASDAQ: CNTG) Centogene Nv stock price per share is $1.31 today (as of Feb 3, 2023).

What is Centogene Nv's Market Cap?

(NASDAQ: CNTG) Centogene Nv's market cap is $35.34M, as of Feb 6, 2023.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Centogene Nv's market cap is calculated by multiplying CNTG's current stock price of $1.31 by CNTG's total outstanding shares of 27,081,557.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.